Trials / Unknown
UnknownNCT02916654
Sucrosomial Iron in Patients With Celiac Disease and IDA
Sucrosomial Iron Supplementation in Anaemic Patients With Celiac Disease Not Tolerating Oral Ferrous Sulfate
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Sucrosomial iron (Sideral® Forte) is a preparation of ferric pyrophosphate conveyed within a phospholipid membrane associated with ascorbic acid, is a new-generation oral iron which shows a high gastrointestinal absorption and high bioavailability with a low incidence of side effects due to lack of any direct contact with intestinal mucosa. In comparison with the other standard oral iron preparations, sucrosomial iron seems to be a promising new strategy of iron replacement in CD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | sucrosomial iron | administration of sucrosomial iron |
| DRUG | Sulphate iron | administration of sulphate iron |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-08-01
- Completion
- 2017-12-01
- First posted
- 2016-09-27
- Last updated
- 2017-03-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02916654. Inclusion in this directory is not an endorsement.